Suzhou Fushilai Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 397.98 million compared to CNY 352.64 million a year ago. Revenue was CNY 397.98 million compared to CNY 352.64 million a year ago.

Net income was CNY 127.13 million compared to CNY 86.18 million a year ago. Basic earnings per share from continuing operations was CNY 1.513 compared to CNY 1.2535 a year ago. Diluted earnings per share from continuing operations was CNY 1.513 compared to CNY 1.2535 a year ago.